KATHLEEN M. WILTSEY

Corporate Board Profile

Tech Score: 0/100

LEXICON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2008-03-14	Kathleen M. Wiltsey has been a director since February 2007. ... The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Kathleen M. Wiltsey. ... The following table presents summary information for the year ended December 31, 2007 regarding the compensation of the non-employee members of our board of directors. ... Kathleen M. Wiltsey $24,243 Fees Earned or Paid in Cash, $16,140 Option Awards, Total $40,383.
2009-03-13	The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Kathleen M. Wiltsey. The board of directors, in its business judgment, has determined that Dr. Barker, Mr. Palantoni and Ms. Wiltsey are “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc.

Filing Date

Source Excerpt

2008-03-14

Kathleen M. Wiltsey has been a director since February 2007. ... The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Kathleen M. Wiltsey. ... The following table presents summary information for the year ended December 31, 2007 regarding the compensation of the non-employee members of our board of directors. ... Kathleen M. Wiltsey $24,243 Fees Earned or Paid in Cash, $16,140 Option Awards, Total $40,383.

2009-03-13

The current members of our audit committee are Samuel L. Barker, Ph.D. (chair), Frank P. Palantoni and Kathleen M. Wiltsey. The board of directors, in its business judgment, has determined that Dr. Barker, Mr. Palantoni and Ms. Wiltsey are “independent” in accordance with the applicable listing standards of The Nasdaq Stock Market, Inc.

Data sourced from SEC filings. Last updated: 2026-03-09